Cargando…

Adult-onset Still's disease following mRNA COVID-19 vaccination

Detalles Bibliográficos
Autores principales:	Sharabi, Amir, Shiber, Shachaf, Molad, Yair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575550/ https://www.ncbi.nlm.nih.gov/pubmed/34763089 http://dx.doi.org/10.1016/j.clim.2021.108878

Ejemplares similares

Diagnostic utility of clinical characteristics, laboratory tests, and serum ferritin in diagnosis of adult-onset Still disease
por: Sagy, Iftach, et al.
Publicado: (2022)

Association of the Charlson Comorbidity Index with Renal Outcome and All-Cause Mortality in Antineutrophil Cytoplasmatic Antibody-Associated Vasculitis
por: Ofer-Shiber, Shachaf, et al.
Publicado: (2014)

Adult-onset Still's disease after mRNA COVID-19 vaccine
por: Magliulo, Daniel, et al.
Publicado: (2021)

Painless thyroiditis following mRNA vaccination for COVID-19
por: Nakaizumi, Nobuhiko, et al.
Publicado: (2022)

Panuveitis following mRNA-based COVID-19 vaccine
por: Bouayad, A., et al.
Publicado: (2023)

Membranous nephropathy following anti–COVID-19 mRNA vaccination
por: Gueguen, Lorraine, et al.
Publicado: (2021)

Elevated Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 Level in Patients with Acute Coronary Syndrome (ACS): A Biomarker of Disease Severity and Outcome
por: Shiber, Shachaf, et al.
Publicado: (2021)

Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report
por: Iwata, Masahiro, et al.
Publicado: (2022)

New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report
por: Bianco, Assunta, et al.
Publicado: (2022)

Successful alternative vaccination with BNT162b2 mRNA COVID-19 vaccine for new-onset IgA vasculitis after receiving mRNA-1273—case report
por: Morioka, Fumiyuki, et al.
Publicado: (2022)

Myocarditis and COVID-19 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?
por: Anzola, Ana M., et al.
Publicado: (2022)

Thromboembolic events following mRNA vaccines for COVID 19: a case series
por: Serrao, Alessandra, et al.
Publicado: (2022)

No evidence of an increased risk for cardiac complications following mRNA COVID-19 vaccines
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2023)

No evidence of an increased risk for cardiac complications following mRNA COVID-19 vaccines
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2023)

Flare of adult-onset Still’s disease following mRNA COVID-19 vaccination: a case report and review of literature
por: Kim, Ji-Won, et al.
Publicado: (2022)

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Ramsay Hunt syndrome following mRNA SARS-COV-2 vaccine()
por: Rodríguez-Martín, Minerva, et al.
Publicado: (2022)

Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2021)

Acute gastric and non-mesenteric colonic infarction following mRNA COVID-19 vaccination
por: Lee, Taek-Gu, et al.
Publicado: (2022)

Adult-onset Still’s Disease after BNT162b2 mRNA COVID-19 Vaccine
por: Park, Seong Yeon, et al.
Publicado: (2021)

Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality?
por: Pasin, Federico, et al.
Publicado: (2021)

Temporal metabolic response and mRNA COVID-19 vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis
por: Faissner, Simon, et al.
Publicado: (2021)

Effectiveness of mRNA Covid-19 vaccine in healthcare workers
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Effectiveness of mRNA Covid-19 vaccine in healthcare workers
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

COVID-19 mRNA vaccination in patients with previous myocarditis
por: Pieroni, Maurizio, et al.
Publicado: (2022)

Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2022)

Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report
por: Masuccio, Fabio Giuseppe, et al.
Publicado: (2021)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

Successful treatment with tacrolimus of refractory adult-onset Still's disease
por: Ohe, Masashi, et al.
Publicado: (2014)

Adult-onset Still’s disease complicated by Guillain-Barré syndrome
por: Farina, Nicola, et al.
Publicado: (2023)

New-onset Evans syndrome in a patient with SLE post SARS-CoV2 mRNA vaccination
por: Ng, Timothy Y. M., et al.
Publicado: (2022)

Corticosteroids and mRNA Vaccines: A Word of Caution
por: Zhong, Zifu, et al.
Publicado: (2021)

Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
por: Kervella, Delphine, et al.
Publicado: (2021)

Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines
por: Teo, Shyh Poh
Publicado: (2021)

HeartWare Thrombosis After mRNA COVID-19 Vaccination
por: Schettle, Sarah, et al.
Publicado: (2022)

Livedoid skin reaction and mRNA Covid-19 vaccine: correspondence
por: Mungunpuntipantip, Rujittika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ni34jd2ud1hs09dttrqmhh78og